{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:38:37Z","timestamp":1793277517181,"version":"4.5.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immune deficiency disorder characterized by thrombocytopenia, small platelet size, eczema, recurrent infections, and increased risk of autoimmune disorders and malignancies. X-linked thrombocytopenia (XLT) is an allelic variant of WAS which presents with a milder phenotype, generally limited to thrombocytopenia. WAS and XLT are caused by mutations of the Wiskott-Aldrich syndrome protein (WASP) gene which encodes a 502-amino acid protein, named WASP. WASP is thought to play a role in actin cytoskeleton organization and cell signaling. Here, we report the identification of 141 unique mutations, 71 not previously reported, from 227 WAS\/XLT families with a total of 262 affected members. When possible we studied the effects of these mutations on transcription, RNA splicing, and protein expression. By analyzing a large number of patients with WAS\/XLT at the molecular level we identified 5 mutational hotspots in the WASP gene and have been able to establish a strong association between genotype and phenotype. (Blood. 2004;104:4010-4019)<\/jats:p>","DOI":"10.1182\/blood-2003-05-1592","type":"journal-article","created":{"date-parts":[[2004,7,29]],"date-time":"2004-07-29T20:27:15Z","timestamp":1091132835000},"page":"4010-4019","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":286,"title":["Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation"],"prefix":"10.1182","volume":"104","author":[{"given":"Yinzhu","family":"Jin","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Mazza","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinda R.","family":"Christie","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Giliani","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilia","family":"Fiorini","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mella","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gandellini","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donn M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qili","family":"Zhu","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Nelson","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, Seattle; the Istituto di Medicina Molecolare \u201cAngelo Nocivelli,\u201d Department of Pediatrics, University of Brescia, Brescia, Italy; and the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218564218600_REF1","unstructured":"Wiskott A. Familia\u0308rer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd.1937;68: 212-216."},{"key":"2020021218564218600_REF2","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr.1994;125: 876-885.","DOI":"10.1016\/S0022-3476(05)82002-5"},{"key":"2020021218564218600_REF3","doi-asserted-by":"crossref","unstructured":"Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood.1980;55: 243-252.","DOI":"10.1182\/blood.V55.2.243.243"},{"key":"2020021218564218600_REF4","doi-asserted-by":"crossref","unstructured":"Badolato R, Sozzani S, Malacarne F, et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol.1998;161: 1026-1033.","DOI":"10.4049\/jimmunol.161.2.1026"},{"key":"2020021218564218600_REF5","doi-asserted-by":"crossref","unstructured":"Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol.1998;28: 3259-3267.","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B"},{"key":"2020021218564218600_REF6","doi-asserted-by":"crossref","unstructured":"Rawlings SL, Crooks GM, Bockstoce D, Barsky LW, Parkman R, Weinberg KI. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression. Blood.1999;94: 3872-3882.","DOI":"10.1182\/blood.V94.11.3872"},{"key":"2020021218564218600_REF7","unstructured":"Rengan R, Ochs HD. Molecular biology of the Wiskott-Aldrich syndrome. Rev Immunogenet.2000;2: 243-255."},{"key":"2020021218564218600_REF8","doi-asserted-by":"crossref","unstructured":"Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol.2000;6: 477-485.","DOI":"10.1023\/A:1026416017763"},{"key":"2020021218564218600_REF9","doi-asserted-by":"crossref","unstructured":"Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell.1994;78: 635-644.","DOI":"10.1016\/0092-8674(94)90528-2"},{"key":"2020021218564218600_REF10","doi-asserted-by":"crossref","unstructured":"Villa A, Notarangelo L, Macchi P, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet.1995;9: 414-417.","DOI":"10.1038\/ng0495-414"},{"key":"2020021218564218600_REF11","doi-asserted-by":"crossref","unstructured":"Zhu Q, Zhang M, Blaese RM, et al. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood.1995;86: 3797-3804.","DOI":"10.1182\/blood.V86.10.3797.bloodjournal86103797"},{"key":"2020021218564218600_REF12","doi-asserted-by":"crossref","unstructured":"Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet.2001;27: 313-317.","DOI":"10.1038\/85886"},{"key":"2020021218564218600_REF13","doi-asserted-by":"crossref","unstructured":"Nonoyama S, Ochs HD. Wiskott-Aldrich syndrome. Curr Allergy Asthma Rep.2001;1: 430-437.","DOI":"10.1007\/s11882-001-0028-0"},{"key":"2020021218564218600_REF14","doi-asserted-by":"crossref","unstructured":"Machesky LM, Insall RH. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2\/3 complex. Curr Biol.1998;8: 1347-1356.","DOI":"10.1016\/S0960-9822(98)00015-3"},{"key":"2020021218564218600_REF15","doi-asserted-by":"crossref","unstructured":"Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome\/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood.1997;90: 2680-2689.","DOI":"10.1182\/blood.V90.7.2680"},{"key":"2020021218564218600_REF16","doi-asserted-by":"crossref","unstructured":"Remold-O'Donnell E, Cooley J, Shcherbina A, et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol.1997;158: 4021-4025.","DOI":"10.4049\/jimmunol.158.9.4021"},{"key":"2020021218564218600_REF17","doi-asserted-by":"crossref","unstructured":"Lemahieu V, Gastier JM, Francke U. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum Mutat.1999;14: 54-66.","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<54::AID-HUMU7>3.0.CO;2-E"},{"key":"2020021218564218600_REF18","doi-asserted-by":"crossref","unstructured":"Wengler GS, Notaragelo LD, Berardelli S, et al. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood.1995;86: 3648-3654.","DOI":"10.1182\/blood.V86.10.3648.bloodjournal86103648"},{"key":"2020021218564218600_REF19","doi-asserted-by":"crossref","unstructured":"Imai K, Zhu Y, Jin Y, et al. Clinical course of patients with WASP gene mutations. Blood.2004;103: 456-464.","DOI":"10.1182\/blood-2003-05-1480"},{"key":"2020021218564218600_REF20","doi-asserted-by":"crossref","unstructured":"Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott-Aldrich syndrome: no strict genotypephenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet.1996;98: 68-76.","DOI":"10.1007\/s004390050162"},{"key":"2020021218564218600_REF21","doi-asserted-by":"crossref","unstructured":"Greer WL, Shehabeldin A, Schulman J, Junker A, Siminovitch KA. Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome. Hum Genet.1996;98: 685-690.","DOI":"10.1007\/s004390050285"},{"key":"2020021218564218600_REF22","doi-asserted-by":"crossref","unstructured":"Kwan SP, Hagemann TL, Blaese RM, Knutsen A, Rosen FS. Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum Mol Genet.1995;4: 1995-1998.","DOI":"10.1093\/hmg\/4.10.1995"},{"key":"2020021218564218600_REF23","doi-asserted-by":"crossref","unstructured":"Notarangelo LD, Mazza C, Giliani S, et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood.2002;99: 2268-2269.","DOI":"10.1182\/blood.V99.6.2268"},{"key":"2020021218564218600_REF24","unstructured":"Ochs HD. The Wiskott-Aldrich syndrome. Isr Med Assoc J.2002;4: 379-384."},{"key":"2020021218564218600_REF25","doi-asserted-by":"crossref","unstructured":"Levitt D, Ochs HD, Wedgwood RJ. Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM. J Clin Immunol.1984;4: 143-150.","DOI":"10.1007\/BF00915048"},{"key":"2020021218564218600_REF26","doi-asserted-by":"crossref","unstructured":"Raskind WH, Niakan KK, Wolff J, et al. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia. Blood.2000;95: 2262-2268.","DOI":"10.1182\/blood.V95.7.2262"},{"key":"2020021218564218600_REF27","doi-asserted-by":"crossref","unstructured":"Derry JM, Kerns JA, Weinberg KI, et al. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum Mol Genet.1995;4: 1127-1135.","DOI":"10.1093\/hmg\/4.7.1127"},{"key":"2020021218564218600_REF28","doi-asserted-by":"crossref","unstructured":"Giliani S, Fiorini M, Mella P, et al. Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysis. Prenat Diagn.1999;19: 36-40.","DOI":"10.1002\/(SICI)1097-0223(199901)19:1<36::AID-PD458>3.0.CO;2-V"},{"key":"2020021218564218600_REF29","doi-asserted-by":"crossref","unstructured":"Stewart DM, Treiber-Held S, Kurman CC, Facchetti F, Notarangelo LD, Nelson DL. Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest.1996;97: 2627-2634.","DOI":"10.1172\/JCI118712"},{"key":"2020021218564218600_REF30","doi-asserted-by":"crossref","unstructured":"Schwarz K. WASPbase: a database of WAS- and XLT-causing mutations. Immunol Today.1996;17: 496-502.","DOI":"10.1016\/S0167-5699(96)80901-7"},{"key":"2020021218564218600_REF31","doi-asserted-by":"crossref","unstructured":"Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A.2001;98: 8697-8702.","DOI":"10.1073\/pnas.151260498"},{"key":"2020021218564218600_REF32","doi-asserted-by":"crossref","unstructured":"Kolluri R, Shehabeldin A, Peacocke M, et al. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeniety at the WAS locus. Hum Mol Genet.1995;4: 1119-1126.","DOI":"10.1093\/hmg\/4.7.1119"},{"key":"2020021218564218600_REF33","doi-asserted-by":"crossref","unstructured":"Kwan SP, Hagemann TL, Radke BE, Blaese RM, Rosen FS. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc Natl Acad Sci U S A.1995;92: 4706-4710.","DOI":"10.1073\/pnas.92.10.4706"},{"key":"2020021218564218600_REF34","doi-asserted-by":"crossref","unstructured":"de Saint Basile G, Lagelouse RD, Lambert N, et al. Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J Pediatr.1996;129: 56-62.","DOI":"10.1016\/S0022-3476(96)70190-7"},{"key":"2020021218564218600_REF35","doi-asserted-by":"crossref","unstructured":"Schwartz M, Bekassy A, Donner M, et al. Mutation spectrum in patients with Wiskott-Aldrich syndrome and X-linked thromboctyopenia: identification of twelve different mutations in the WASP gene. Thromb Haemost.1996;75: 546-550.","DOI":"10.1055\/s-0038-1650318"},{"key":"2020021218564218600_REF36","doi-asserted-by":"crossref","unstructured":"Chan S, Hui Y, Lau Y. An 11-bp deletion in exon 10 (c1295del11) of WASP responsible for Wiskott-Aldrich syndrome. Hum Mutat.1999;13: 507-508.","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<507::AID-HUMU21>3.0.CO;2-8"},{"key":"2020021218564218600_REF37","doi-asserted-by":"crossref","unstructured":"Thompson LJ, Lalloz MR, Layton DM. Unique and recurrent WAS gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis.1999;25: 218-226.","DOI":"10.1006\/bcmd.1999.0247"},{"key":"2020021218564218600_REF38","doi-asserted-by":"crossref","unstructured":"Brooimans RA, Van Den Bert AJ, Tamminga RY, Reesz T, Wulffraat NM, Zegers BJ. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome. Hum Mutat.2000;15: 386-387.","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<386::AID-HUMU24>3.0.CO;2-1"},{"key":"2020021218564218600_REF39","unstructured":"Itoh S, Nonoyama S, Moria T, et al. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Int J Hematol.2000;71: 79-83."},{"key":"2020021218564218600_REF40","doi-asserted-by":"crossref","unstructured":"Kanegane H, Nomura K, Miyawaki T, et al. X-linked thrombocytopenia identified by flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes. Blood.2000;95: 1110-1111.","DOI":"10.1182\/blood.V95.3.1110"},{"key":"2020021218564218600_REF41","doi-asserted-by":"crossref","unstructured":"Rottem M, Alon-Shalev S, Shneor Y, Hujeirat Y. Wiskott Aldrich syndrome in an Israeli family: identification of a novel G40V mutation. Hum Mutat.2000;16: 448.","DOI":"10.1002\/1098-1004(200011)16:5<448::AID-HUMU20>3.0.CO;2-2"},{"key":"2020021218564218600_REF42","doi-asserted-by":"crossref","unstructured":"Sasahara Y, Kawai S, Kumaki S, Ohashi Y, Mine-gishi M, Tsuchiya S. Novel mutations, no detectable mRNA and familial genetic analysis of the Wiskott-Aldrich syndrome protein gene in six Japanese patients with Wiskott-Aldrich syndrome. Eur J Pediatr.2000;159: 23-30.","DOI":"10.1007\/s004310050005"},{"key":"2020021218564218600_REF43","doi-asserted-by":"crossref","unstructured":"Fillat C, Espanol T, Oset M, Ferrando M, Estivill X, Volpini V. Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome. Am J Med Genet.2001;100: 116-121.","DOI":"10.1002\/ajmg.1228"},{"key":"2020021218564218600_REF44","doi-asserted-by":"crossref","unstructured":"Ho LL, Ayling J, Prosser I, Kronenberg H, Iland H, Joshua D. Missense C168T in the Wiskott-Aldrich syndrome protein gene is a common mutation in X-linked thrombocytopenia. Br J Hematol.2001;112: 76-80.","DOI":"10.1046\/j.1365-2141.2001.02465.x"},{"key":"2020021218564218600_REF45","doi-asserted-by":"crossref","unstructured":"Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest.1998;102: 2146-2155.","DOI":"10.1172\/JCI5084"},{"key":"2020021218564218600_REF46","doi-asserted-by":"crossref","unstructured":"Shcherbina A, Candotti F, Rosen FS, Remold-O'Donnell E. High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients. Br J Haematol.2003;121: 529-530.","DOI":"10.1046\/j.1365-2141.2003.04310.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4010\/1704777\/zh802404004010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4010\/1704777\/zh802404004010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T23:22:40Z","timestamp":1682724160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/13\/4010\/19014\/Mutations-of-the-WiskottAldrich-Syndrome-Protein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,15]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-05-1592","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,15]]}}}